E-LIB Suche - Ergebnisse für: Van Campenhout, H.

1

108P Real-world (RW) effectiveness and safety of adjuvant n..:

Neyns, B. ; Willemot, L. ; McDonald, L....
Immuno-Oncology and Technology. 20 (2023) - p. 100580 , 2023

Link: https://doi.org/10.1016/..

2

PCN142 COST-EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH ..:

Baker, T. ; Paly, V.F. ; Johnson, H.M....
Value in Health. 22 (2019) - p. S462-S463 , 2019

Link: https://doi.org/10.1016/..

3

PCN89 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT..:

Van Campenhout, H. ; Teitsson, S. ; Orsini, I...
Value in Health. 22 (2019) - p. S453 , 2019

Link: https://doi.org/10.1016/..

4

P206 A DESCRIPTIVE STUDY OF CARDIOVASCULAR RISK MANAGEMENT ..:

Svilaas, A. ; McGrath, C. ; van Campenhout, H....
Atherosclerosis Supplements. 11 (2010) 2 - p. 59-60 , 2010

Link: https://doi.org/10.1016/..

5

PUK22 AN OBSERVATIONAL STUDY ON THE HEALTH-RELATED QUALITY ..:

De Ridder, D ; Ackaert, K ; Dewilde, L...
Value in Health. 10 (2007) 6 - p. A319-A320 , 2007

Link: https://doi.org/10.1016/..

6

PIN16 AN OBSERVATIONAL HEALTH-ECONOMIC ANALYSIS OF THE TREA..:

Van Campenhout, H ; De Mees, V ; Marbaix, S.
Value in Health. 9 (2006) 6 - p. A303-A304 , 2006

Link: https://doi.org/10.1016/..

7

PCV3 A PHARMACO-ECONOMIC EVALUATION OF AGGRESSIVE CHOLESTER..:

Annemans, L ; Van Campenhout, H ; Matthys, K..
Value in Health. 8 (2005) 6 - p. A89 , 2005

Link: https://doi.org/10.1016/..

8

PPN5 PROSPECTIVE ASSESSMENT OF THE HEALTH AND ECONOMIC BURD..:

Annemans, L ; Van Campenhout, H ; Maeyaert, J.
Value in Health. 7 (2004) 6 - p. 726 , 2004

Link: https://doi.org/10.1016/..

9

Morphometric Analysis of Human Bone Biopsies: A Quantitativ..:

Müller, R ; Van Campenhout, H ; Van Damme, B...
Bone. 23 (1998) 1 - p. 59-66 , 1998

Link: https://doi.org/10.1016/..

10

Bone ingrowth in total knee arthroplasty: The impact of HA-..:

Labey, L. ; Van Campenhout, H. ; Vander Sloten, J....
Journal of Biomechanics. 31 (1998) - p. 26 , 1998

Link: https://doi.org/10.1016/..

11

Histomorphometrical analysis as a tool for the analysis of ..:

Van Campenhout, H. ; Lowet, G. ; Van der Perre, G...
Osteoporosis International. 6 (1996) S1 - p. 175-175 , 1996

Link: https://doi.org/10.1007/..

12

Microarchitectural analysis of bone biopsies: Histology ver..:

Van Campenhout, H. ; Müller, R. ; Van Damme, B....
Bone. 19 (1996) 3 - p. 165 , 1996

Link: https://doi.org/10.1016/..

13

Addition of PEG‐interferon to long‐term nucleos(t)ide analo..:

Farag, Mina S. ; van Campenhout, Margo J. H. ; Sonneveld, M. J....
Journal of Viral Hepatitis. 31 (2024) 4 - p. 197-207 , 2024

Link: https://doi.org/10.1111/..

14

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk..:

Brakenhoff, Sylvia M. ; de Knegt, Robert J. ; van Campenhout, Margo J.H....
Journal of Microbiology, Immunology and Infection. 56 (2023) 1 - p. 31-39 , 2023

Link: https://doi.org/10.1016/..

15

Serum hepatitis B virus RNA predicts response to peginterfe..:

van Campenhout, Margo J. H. ; van Bömmel, Florian ; Pfefferkorn, Maria...
Journal of Viral Hepatitis. 27 (2020) 6 - p. 610-619 , 2020

Link: https://doi.org/10.1111/..